{
    "clinical_study": {
        "@rank": "120977", 
        "arm_group": {
            "arm_group_label": "two stage hepatectomy", 
            "arm_group_type": "Experimental", 
            "description": "the two stage hepatectomy is defined as a two step procedure: first step: hepatotomy with ligature of the right branch of the portal vein second step (one week after the first step): right hepatectomy"
        }, 
        "brief_summary": {
            "textblock": "The aim of this study is evaluate the feasibility of early two-stage hepatectomy in patients\n      with liver metastasis from colorectal cancer."
        }, 
        "brief_title": "ALPPS (Liver Partition and Portal Vein Ligation) for Two-stage Hepatectomy for Colorectal Liver Metastasis", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Colorectal Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Colorectal Neoplasms", 
                "Neoplasm Metastasis", 
                "Liver Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "In France, each year around 36,000 new cases of colorectal cancers are registered\n      responsible in 16,000 deaths because of liver metastasis.\n\n      In case of bilobar metastasis, classic two-stage hepatectomy with portal embolization could\n      be performed.\n\n      An alternative to the classic surgery, early two stage hepatectomy, could be proposed to\n      simplify the patient's management and to improve the resectability."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  potentially resectable liver metastasis from colorectal cancer\n\n          -  portal embolisation required\n\n          -  older than 18 years old\n\n        Exclusion Criteria:\n\n          -  synchronous surgery on the colon or the rectum\n\n          -  extra hepatic metastasis\n\n          -  history of hepatectomy\n\n          -  pregnancy or breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01842971", 
            "org_study_id": "PI 2012-843-0028", 
            "secondary_id": "A41707-36"
        }, 
        "intervention": {
            "arm_group_label": "two stage hepatectomy", 
            "intervention_name": "two stage hepatectomy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "two stage hepatectomy", 
            "liver metastasis", 
            "colorectal cancer"
        ], 
        "lastchanged_date": "November 26, 2013", 
        "location": {
            "contact": {
                "email": "regimbeau.jean-marc@chu-amiens.fr", 
                "last_name": "jean marc regimbeau, MD, PhD", 
                "phone": "+33 3 22 66 83 00"
            }, 
            "facility": {
                "address": {
                    "city": "Amiens", 
                    "country": "France", 
                    "zip": "80054"
                }, 
                "name": "Amiens University Hospital"
            }, 
            "investigator": {
                "last_name": "jean marc regimbeau, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Associating Liver Partition and Portal Vein Ligation (ALPPS) for Potentially Resectable Liver Metastasis From Colorectal Cancer: Prospective Evaluation of the Early Two-stage Hepatectomy by the Simon's Methods", 
        "overall_contact": {
            "email": "regimbeau.jean-marc@chu-amiens.fr", 
            "last_name": "jean marc regimbeau, MD, PhD", 
            "phone": "+33322668300"
        }, 
        "overall_official": {
            "affiliation": "Amiens University Hospital", 
            "last_name": "jean marc regimbeau, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Committee for the Protection of Personnes", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the number of complete surgical procedure is defined as the number of patients in whom the two stage hepatectomy is complete.", 
            "measure": "number of complete surgical procedure", 
            "safety_issue": "No", 
            "time_frame": "postoperative week 4"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01842971"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "the overall mortality is defined as the number of patients who are dead at one year after the surgery", 
                "measure": "overall mortality", 
                "safety_issue": "Yes", 
                "time_frame": "one year after the two stage hepatectomy"
            }, 
            {
                "description": "the hepatocellular insufficiency is defined by a prothrombin rate below 50%", 
                "measure": "number of patient with hepatocellular insufficiency", 
                "safety_issue": "Yes", 
                "time_frame": "postoperative day 30"
            }, 
            {
                "description": "the overall morbidity is classified according to the Dindo Clavien classification", 
                "measure": "overall morbidity", 
                "safety_issue": "Yes", 
                "time_frame": "postoperative day 30"
            }, 
            {
                "description": "the remnant liver volume is evaluated with the Myrian Software and calculated by the radiologist", 
                "measure": "preoperative liver volumetry", 
                "safety_issue": "No", 
                "time_frame": "one week prior to the surgery"
            }, 
            {
                "description": "the quality of life is evaluated thanks to the EORTC QLQ C30 LMC 21 form the day before the first stage surgery and the day before the second stage surgery.", 
                "measure": "quality of life", 
                "safety_issue": "No", 
                "time_frame": "the day before the first stage surgery and the day before the second stage surgery"
            }
        ], 
        "source": "Centre Hospitalier Universitaire, Amiens", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire, Amiens", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}